The complete list of mutations from this meta-analysis enriched in metastases or primary tumors includes well-established oncogenes and tumor suppressors such as AR, TP53, PTEN, RB1, APC, MYC, and CTNNB1 and is provided in Supplementary Table S15. This evidence concerns the gene TP53 and neoplasm.